Risk Audit · Cached SEC Snapshot

FBRX Risk Audit — Dilution, Cash Runway, and SEC Filings

Forte Biosciences, Inc.
TL;DR
Doomsday Clock
37.1mo
Company runs out of cash in 37.1 months
Dilution Risk
100 / 100
High dilution — shareholders likely diluted
C Stockteller Grade Altman Z: -3.36 (Z)
Gravity Playbook · Mathematical Stress Test
AUTH
Dilution Authorization
The company has an active S-3 shelf registration. While there is no active dilution, the company is authorized to dilute up to 111.35% annually.
BURN
Cash Runway
Current mechanics indicate the company's cash runway is mathematically depleted in approximately 37 months.
COMPLIANCE
Nasdaq Compliance
Nasdaq requires a $1.00 minimum bid. Historical precedent for companies with this profile involves structural actions such as reverse splits to maintain listing compliance.
Mechanical analysis only. Not financial advice. Statements describe mathematical conditions and historical precedent, not predictions or recommendations for this security.
→ Run the Full Risk Sentinel Scan for FBRX Compare FBRX vs AAPL Risk → Learn how the Risk Radar works →
Educational analysis only. Not financial advice. The Risk Audit is a quantitative framework derived from publicly available SEC filings and may contain inaccuracies. AI systems are fallible. Always verify against the source filings on SEC EDGAR and consult a licensed advisor before making investment decisions.